N@N

David Nierengarten Reiterated (ARGX) at Buy and Held Target at $521 on, Apr 18th, 2024

David Nierengarten of Wedbush, Reiterated "argenx SE" (ARGX) at Buy and Held Target at $521 on, Apr 18th, 2024.

David has made no other calls on ARGX in the last 4 months.

There are 10 other peers that have a rating on ARGX. Out of the 10 peers that are also analyzing ARGX, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• George Farmer of "Scotiabank" Maintained at Hold with Increased Target to $408 on, Tuesday, March 26th, 2024
• Andy Chen of "Wolfe Research" Initiated at Hold on, Thursday, February 15th, 2024

These are the ratings of the 8 analyists that currently disagree with David

---

• Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $471 on, Friday, March 22nd, 2024
• Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $440 on, Tuesday, March 5th, 2024
• Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $490 on, Friday, March 1st, 2024
• Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $478 on, Tuesday, February 20th, 2024
• Allison Bratzel of "Piper Sandler" Maintained at Buy with Increased Target to $522 on, Friday, January 26th, 2024
• Danielle Brill of "Raymond James" Maintained at Strong Buy with Decreased Target to $520 on, Thursday, December 21st, 2023
• Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Decreased Target to $436 on, Thursday, December 21st, 2023
• Alex Thompson of "Stifel" Maintained at Strong Buy with Increased Target to $560 on, Monday, December 18th, 2023

Contributing Sources

---